Results 31 to 40 of about 44,798 (290)

The resource-based view: a tool of key competency for competitive advantage [PDF]

open access: yesProblems and Perspectives in Management, 2019
The increasing turmoil in the external organizational setting or business environment has focused attention on capabilities and resources as the primary source of competitive advantage.
Akwesi Assensoh-Kodua
doaj   +1 more source

Supply chain management as the key to a firm’s strategy in the global marketplace [PDF]

open access: yes, 2015
Purpose: This research aims to analyze the intersection of two literature streams: that of strategy and supply chain management (SCM). This review should create a better understanding of “strategic SCM” by focusing on relevant theories in the strategic ...
Dr Xenophon Koufteros   +4 more
core   +1 more source

Interferon convencional versus interferon peguilado associados à ribavirina no tratamento de pacientes coinfectados pelo vírus da hepatite C (genótipo 1) e da imunodeficiência humana Alpha-interferon versus peg-interferon associated to ribavirin in the treatment of genotype 1 hepatitis C virus and human imunodeficiency virus coinfected patients

open access: yesArquivos de Gastroenterologia, 2009
CONTEXTO: Tem sido sugerido que os pacientes coinfectados por vírus da hepatite C e da imunodeficiência humana (VHC/HIV) devam ser tratados com interferon peguilado associado à ribavirina (PEG+RBV) porque as taxas de resposta virológica sustentada seriam
Paulo Roberto Lerias de Almeida   +5 more
doaj   +1 more source

Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need. [PDF]

open access: yes, 2016
There have been dramatic advancements in the treatment of chronic hepatitis C (HCV) infection. This is largely due to the approval of several direct-acting antiviral agents (DAAs) from a variety of medication classes with novel mechanisms of action ...
Bidell, Monique R   +4 more
core   +2 more sources

Multicenter Experience using Ledipasvir/Sofosbuvir ± RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment

open access: yesAnnals of Hepatology, 2018
Introduction and aim. Approximately 10%-15% of patients with hepatitis C genotype 1 (HCV GT1) experience virological relapse after all-oral antiviral regimen using simeprevir (SMV) and sofosbuvir (SOF).
Bashar Aqel   +6 more
doaj   +1 more source

Human Resources and the Resource Based View of the Firm [PDF]

open access: yes, 2001
The resource-based view (RBV) of the firm has influenced the field of strategic human resource management (SHRM) in a number of ways. This paper explores the impact of the RBV on the theoretical and empirical development of SHRM.
Argote, L.   +90 more
core   +2 more sources

Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.

open access: yesPLoS ONE, 2018
BackgroundGenetic variants of inosine triphosphatase (ITPA) that confer reduced ITPase activity are associated with protection against ribavirin(RBV)-induced hemolytic anemia in peginterferon(IFN)/RBV-based treatment of hepatitis C virus (HCV).
Aparna Vasanthakumar   +8 more
doaj   +1 more source

Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment

open access: yesTherapeutic Drug Monitoring, 2012
The response rate to treatment of chronic hepatitis C virus-genotype 1 and 4 infections was recently found to be strongly influenced by many polymorphisms. The aim of our study was to carry out an integrated analysis of the effects of polymorphisms and ribavirin (RBV) plasma exposure on outcome.The retrospective analysis included 174 patients.
Dʼavolio A   +16 more
openaire   +3 more sources

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection. [PDF]

open access: yesPLoS ONE, 2015
Nitazoxanide (NTZ) plus pegylated interferon and ribavirin (Peg-IFN/RBV) improved the sustained virological response (SVR) achieved with Peg-IFN/RBV in hepatitis C virus genotype 4 (HCV-4)-monoinfected patients.
Juan Macías   +9 more
doaj   +1 more source

Competitive Advantages as a Complete Mediator Variable in Strategic Resources, Dynamic Capabilities and Performance Relations in the Car Sales Sector [PDF]

open access: yes, 2018
Taking the resource-based view –RBV- and the dynamic capability view –DCV- as an orientation, the main aim of this study is to develop the mediator role that competitive advantages play in the relations between strategic resources, dynamic capabilities ...
Navarro García, Antonio   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy